Last Updated : October 29, 2013
Details
FilesGeneric Name:
Fluticasone furoate /vilanterol
Project Status:
Complete
Therapeutic Area:
Chronic Obstructive Pulmonary Disease (COPD)
Manufacturer:
GlaxoSmithKline
Call for patient/clinician input open:
Brand Name:
Breo Ellipta
Project Line:
Reimbursement Review
Project Number:
SR0358-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Chronic Obstructive Pulmonary Disease (COPD)
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : October 29, 2013